Description of 68 Companies and Market Analysis for the Years 2002-2007 is Obtainable inside Transdermal Drug Delivery - Technologies, Markets, and Companies.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/ c1450) has announced the addition of Transdermal Drug Delivery - Technologies, Markets, and Companies to their offering. Transdermal drug delivery is an approach used to deliver drugs through the skin for therapeutic use as an alternative to oral, intravascular intravascular /in·tra·vas·cu·lar/ (in?trah-vas´ku-lar) within a vessel. in·tra·vas·cu·lar adj. Within one or more blood vessels. , subcutaneous and transmucosal routes. Various transdermal drug delivery technologies are described in this report including the use of suitable formulations, carriers and penetration enhancers. The most commonly used transdermal system is the skin patch skin patch, transdermal patch, or transdermal delivery system, adhesive patch used to deliver a controlled dose of a drug through the skin over a period of time. using various types of technologies. Transdermal technologies may be applied for several categories of pharmaceuticals used for the treatment of disorders of the skin or for systemic effect to treat diseases of other organs. There are eight categories of transdermal products and applications include hormone replacement therapy Hormone Replacement Therapy Definition Hormone replacement therapy (HRT) is the use of synthetic or natural female hormones to make up for the decline or lack of natural hormones produced in a woman's body. , management of pain, angina pectoris, smoking cessation smoking cessation Public health Temporary or permanent halting of habitual cigarette smoking; withdrawal therapies–eg, hypnosis, psychotherapy, group counseling, exposing smokers to Pts with terminal lung CA and nicotine chewing gum are often ineffective. and neurological disorders This is a list of major and frequently observed neurological disorders (e.g. Alzheimer's disease), symptoms (e.g.back pain), signs (e.g. aphasia) and syndromes (e.g. Aicardi syndrome). such as Parkinson's disease Parkinson's disease or Parkinsonism, degenerative brain disorder first described by the English surgeon James Parkinson in 1817. When there is no known cause, the disease usually appears after age 40 and is referred to as Parkinson's disease. . The value of market for transdermal delivery is $8 billion in the year 2002 and is expected to increase to $16.3 billion in the year 2007. Benefits of this report: - Up-to-date one-stop information on transdermal drug delivery - Description of 68 companies involved and 50 collaborations in this area - Market analysis 2002-2007 - Strategies for developing markets for transdermal drug delivery - A selected bibliography of 100 publications Who should read this report? - Biotechnology companies developing transdermal technologies - Drug delivery companies - Pharmaceutical companies interested in transdermal drug delivery - Pharmaceutical research institutes For more information visit (http://www.researchandmarkets.com/reports/ c1450) Source: Jain PharmaBiotech |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion